Castle Biosciences Stock Math Transform Inverse Tangent Over Price Movement
| CSTL Stock | USD 26.60 -0.42 -1.55% |
| Symbol |
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Castle Biosciences Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Castle Biosciences price patterns.
Castle Biosciences Technical Analysis Modules
Most technical analysis of Castle Biosciences help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Castle from various momentum indicators to cycle indicators. When you analyze Castle charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Castle Biosciences Inc
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. The company was founded in 2007 and is headquartered in Friendswood, Texas. Castle Biosciences operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 482 people. Downside history and drawdown behavior provide context for risk expectations in Castle Biosciences. Downside profile remains relatively contained. Castle Biosciences has market cap of 803.34 M, P/E of 87.86, ROE of -5.21%.
Methodology
Unless otherwise specified, financial data for Castle Biosciences is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Castle (USA Stocks:CSTL) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Inputs are aggregated from public filings and market reference sources and public institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR. Certain values may not reflect real-time changes. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Castle Biosciences may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Castle Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Castle Biosciences' short interest history, or implied volatility extrapolated from Castle Biosciences options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested few shares | |
 | ESG Investing Invested few shares | |
 | Momentum Invested over 200 shares | |
 | Driverless Cars Invested over 40 shares | |
 | Power Assets Invested over 200 shares | |
 | Blockchain Invested few shares | |
 | Hedge Favorites Invested over 200 shares | |
 | FinTech Invested over 20 shares | |
 | Artificial Intelligence Invested few shares | |
 | Cash Cows Invested few shares |
More Resources for Castle Stock Analysis
A structured review of Castle Biosciences often starts with core financial statements and trend context. Key ratios help frame profitability, efficiency, and growth context for Castle Biosciences Stock. Highlighted below are reports that provide context for Castle Biosciences Stock:Castle Biosciences has market cap of 803.34 M, P/E of 87.86, operating margin of -4.4%. Trending Equities can help frame allocation decisions. The allocation includes a position in Castle Biosciences inside the allocation mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.Explore our How to Trade Castle Stock guide to learn how to trade Castle Biosciences effectively.Analysis related to Castle Biosciences should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Investors evaluate Castle Biosciences using market value and book value, each describing different facets of the business. Castle Biosciences' market capitalization is 803.34 M. A P/B ratio of 1.71 indicates the market values Castle Biosciences above its accounting book value. Enterprise value stands at 540.74 M. Intrinsic value is an estimate of what Castle Biosciences' fundamentals imply, and it may differ from market and book figures. Analytical frameworks help compare those viewpoints.
Value and price for Castle Biosciences are related but not identical, and they can diverge across cycles. For Castle Biosciences, key inputs include a P/E ratio of 87.86, a P/B ratio of 1.71, a profit margin of -7.02%, ROE of -5.21%. By contrast, market price reflects the level where buyers and sellers transact.